An outbreak of the COVID-19 pandemic is a major public health disease as well as a challenging task to people with comorbidity worldwide. According to a report, comorbidity enhances the risk factors with complications of COVID-19. Here, we propose and explore a mathematical framework to study the transmission dynamics of COVID-19 with comorbidity. Within this framework, the model is calibrated by using new daily confirmed COVID-19 cases in India. The qualitative properties of the model and the stability of feasible equilibrium are studied. The model experiences the scenario of backward bifurcation by parameter regime accounting for progress in susceptibility to acquire infection by comorbidity individuals. The endemic equilibrium is asymptotically stable if recruitment of comorbidity becomes higher without acquiring the infection. Moreover, a larger backward bifurcation regime indicates the possibility of more infection in susceptible individuals. A dynamics in the mean fluctuation of the force of infection is investigated with different parameter regimes. A significant correlation is established between the force of infection and corresponding Shannon entropy under the same parameters, which provides evidence that infection reaches a significant proportion of the susceptible.
In this paper a stochastic order and an aging property have been defined based on R-norm residual entropy, and their properties have been studied. A few useful parametric distributions have been characterized with the help of this entropy. A couple of results have been developed for discrete random variables. AMS {2000} Subject Classification: 94AXX, 94A17.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.